Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christy Finke

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Leukemia|May 1, 2021
Genomic stratification of myelodysplastic/myeloproliferative neoplasms, unclassifiable: Sorting through the unsortedAbhishek A Mangaonkar, David M Swoboda, Terra L Lasho, et al.
Leukemia Research|June 25, 2023
Validation of Molecular International Prognostic Scoring System (IPSS-M) in myelodysplastic/myeloproliferative neoplasms, not otherwise specified (MDS/MPN-NOS)Abhishek A Mangaonkar, David M Swoboda, Terra L Lasho, et al.
Blood Cancer Journal|September 8, 2018
Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal origins of two aggressive neoplasmsMrinal M Patnaik, Terra Lasho, Matthew Howard, et al.
American Journal of Hematology|July 8, 2018
Early thrombotic events and preemptive systemic anticoagulation following splenectomy for myelofibrosisMythri Mudireddy, Naseema Gangat, Terra L Lasho, et al.
American Journal of Hematology|October 13, 2017
Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMMLMrinal M Patnaik, Rangit Vallapureddy, Fevzi F Yalniz, et al.
British Journal of Haematology|December 3, 2015
ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosisAnimesh D Pardanani, Terra L Lasho, Christy Finke, et al.
American Journal of Hematology|February 19, 2016
Calreticulin variant stratified driver mutational status and prognosis in essential thrombocythemiaYoseph C Elala, Terra L Lasho, Naseema Gangat, et al.
Blood Cancer Journal|December 19, 2017
Mutations and karyotype in myelodysplastic syndromes: TP53 clusters with monosomal karyotype, RUNX1 with trisomy 21, and SF3B1 with inv(3)(q21q26.2) and del(11q)Ayalew Tefferi, Dame Idossa, Terra L Lasho, et al.
European Journal of Haematology|June 4, 2014
Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis historyNaseema Gangat, Emnet A Wassie, Terra L Lasho, et al.
Leukemia Research|August 25, 2024
Absence of PNH-clones in DDX41mutant-GPS aids in their distinction from acquired BM failure syndromesYael Kusne, Talha Badar, Terra Lasho, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Leukemia|May 1, 2021
Genomic stratification of myelodysplastic/myeloproliferative neoplasms, unclassifiable: Sorting through the unsortedAbhishek A Mangaonkar, David M Swoboda, Terra L Lasho, et al.
Leukemia Research|June 25, 2023
Validation of Molecular International Prognostic Scoring System (IPSS-M) in myelodysplastic/myeloproliferative neoplasms, not otherwise specified (MDS/MPN-NOS)Abhishek A Mangaonkar, David M Swoboda, Terra L Lasho, et al.
Blood Cancer Journal|September 8, 2018
Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal origins of two aggressive neoplasmsMrinal M Patnaik, Terra Lasho, Matthew Howard, et al.
American Journal of Hematology|July 8, 2018
Early thrombotic events and preemptive systemic anticoagulation following splenectomy for myelofibrosisMythri Mudireddy, Naseema Gangat, Terra L Lasho, et al.
American Journal of Hematology|October 13, 2017
Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMMLMrinal M Patnaik, Rangit Vallapureddy, Fevzi F Yalniz, et al.
British Journal of Haematology|December 3, 2015
ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosisAnimesh D Pardanani, Terra L Lasho, Christy Finke, et al.
American Journal of Hematology|February 19, 2016
Calreticulin variant stratified driver mutational status and prognosis in essential thrombocythemiaYoseph C Elala, Terra L Lasho, Naseema Gangat, et al.
Blood Cancer Journal|December 19, 2017
Mutations and karyotype in myelodysplastic syndromes: TP53 clusters with monosomal karyotype, RUNX1 with trisomy 21, and SF3B1 with inv(3)(q21q26.2) and del(11q)Ayalew Tefferi, Dame Idossa, Terra L Lasho, et al.
European Journal of Haematology|June 4, 2014
Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis historyNaseema Gangat, Emnet A Wassie, Terra L Lasho, et al.
Leukemia Research|August 25, 2024
Absence of PNH-clones in DDX41mutant-GPS aids in their distinction from acquired BM failure syndromesYael Kusne, Talha Badar, Terra Lasho, et al.
Pageof 6